Krystal Biotech, Inc. (KRYS)

Krystal Biotech Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	353.83	344.87	358.33	161.9	341.25	268.27
Short-Term Investments	328.16	252.65	173.85	217.27	96.85	2.99
Cash & Short-Term Investments	681.99	597.52	532.18	379.17	438.1	271.26
Cash Growth	21.87%	12.28%	40.35%	-13.45%	61.50%	40.05%
Receivables	111.44	104.75	42.04	-	-	-
Inventory	31.04	26.51	6.99	-	-	-
Prepaid Expenses	16.88	13.27	6.71	4.61	4.17	3.8
Total Current Assets	841.35	742.05	587.91	383.78	442.27	275.06
Property, Plant & Equipment	158.04	161.45	168.23	169.73	119.58	34.17
Long-Term Investments	138.81	152.11	61.95	4.62	64.37	-
Other Long-Term Assets	0.2	0.23	0.26	0.32	0.07	1.61
Total Assets	1,138	1,056	818.36	558.45	626.3	310.84
Accounts Payable	7.12	4.99	4.13	3.98	8.4	2.11
Accrued Expenses	66.65	52.78	18.15	11.54	6.52	3.99
Current Portion of Leases	1.62	1.22	1.47	1.56	1.04	0.64
Current Income Taxes Payable	8.3	4.29	1.96	0.04	0.08	0.04
Other Current Liabilities	3.21	38.73	7.38	11.72	9.69	8.68
Total Current Liabilities	86.9	102	33.09	28.85	25.74	15.45
Long-Term Leases	8.06	6.04	6.62	7.37	6.98	3.31
Other Long-Term Liabilities	2.79	1.42	-	-	-	-
Total Liabilities	97.75	109.46	39.71	36.22	32.72	18.76
Additional Paid-In Capital	1,146	1,127	1,048	803.72	734.52	363.29
Retained Earnings	-106.6	-180.67	-269.83	-280.76	-140.78	-71.21
Comprehensive Income & Other	1.16	-0.19	0.64	-0.73	-0.16	0.01
Total Common Equity	1,041	946.38	778.64	522.23	593.58	292.08
Shareholders' Equity	1,041	946.38	778.64	522.23	593.58	292.08
Total Liabilities & Equity	1,138	1,056	818.36	558.45	626.3	310.84
Total Debt	9.68	7.26	8.09	8.93	8.02	3.95
Net Cash (Debt)	811.11	742.37	586.04	374.86	494.44	267.32
Net Cash Growth	30.57%	26.68%	56.34%	-24.19%	84.97%	40.38%
Net Cash Per Share	27.13	24.96	21.12	14.70	22.28	14.23
Filing Date Shares Outstanding	28.94	28.81	28.29	25.76	25.21	22.19
Total Common Shares Outstanding	28.93	28.79	28.24	25.76	25.21	19.71
Working Capital	754.45	640.05	554.82	354.93	416.53	259.61
Book Value Per Share	35.97	32.87	27.58	20.27	23.55	14.82
Tangible Book Value	1,041	946.38	778.64	522.23	593.58	292.08
Tangible Book Value Per Share	35.97	32.87	27.58	20.27	23.55	14.82
Buildings	109.15	111.44	111.18	-	-	-
Machinery	36.97	34.19	30.49	12.93	6.51	5.58
Construction In Progress	3.44	5.78	7.29	131.33	104.34	23.03
Leasehold Improvements	27.49	25.67	25.07	24.22	5.72	4.63

Updated Aug 4, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q